Collegium Pharmaceutical Q1 Adj. EPS $1.76 Beats $1.59 Estimate, Sales $193.520M Beat $185.984M Estimate
Collegium Pharmaceutical (NASDAQ:COLL) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.59 by 10.69 percent. This is a 18.12 percent increase over earnings of $1.49 per share